Featured

• 

  RestartResume

  Targeting CKD-aP at the Source: Key Mechanisms and Treatments

  RestartResume

  Targeting CKD-aP at the Source: Key Mechanisms and Treatments

  CME/CE

  Targeting CKD-aP at the Source: Key Mechanisms and Treatments

  Steven Fishbane, MD; Maurizio Gallieni, MD

  0.25 credits

  • 

    

    Steven Fishbane, MD

  • 

    

    Maurizio Gallieni, MD

  0.25 credits

• 

  RestartResume

  Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN

  RestartResume

  Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN

  CME/CE

  Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN

  Chee Kay Cheung, MBChB, MRCP, PhD; Claudia Seikrit, MD

  0.25 credits

  • 

    

    Chee Kay Cheung, MBChB, MRCP, PhD

  • 

    

    Claudia Seikrit, MD

  0.25 credits

• 

  MinuteCE®

  Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach

  James Burton, DM, FRCP; Javed Butler, MD

  1.00 credit 9 episodes

  • 

    

    James Burton, DM, FRCP

  • 

    

    Javed Butler, MD

  • 

    

    Ellie Kelepouris, MD, FACP, FAHA

  • 

    

    Patrick Rossignol, MD, PhD

  1.00 credit 9 episodes

• 

  MinuteCE®

  Decoding Itch in CKD: From CKD-aP Suspicion to Solution

  James Burton, DM, FRCP; Leonie Kraft, MD

  1.00 credit 9 episodes

  • 

    

    James Burton, DM, FRCP

  • 

    

    Leonie Kraft, MD

  • 

    

    Lucio Manenti, MD, PhD

  • 

    

    Emilio Sanchez, MD, PhD

  1.00 credit 9 episodes